Q3 2020 Holdings
Filed 2020-11-16 | 261 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $251.8M | 959,016 | 23.0% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $227.1M | 1,559,805 | 20.8% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $145.3M | 4,151,002 | 13.3% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $79.5M | 351,083 | 7.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $72.1M | 1,886,297 | 6.6% |
| Centene Corp del(CNC) | COM | 15135B101 | $60.3M | 1,033,647 | 5.5% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $42.4M | 1,403,000 | 3.9% |
| Caredx Inc(CDNA) | COM | 14167L103 | $42.3M | 1,115,903 | 3.9% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $40.3M | 78,186 | 3.7% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $38.8M | 1,641,503 | 3.5% |
| Align Technology Inc(ALGN) | COM | 016255101 | $27.7M | 84,635 | 2.5% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $25.7M | 1,403,400 | 2.4% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $11.3M | 39,400 | 1.0% |
| Avantor Inc(AVTR) | COM | 05352A100 | $6.9M | 307,089 | 0.6% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $3.4M | 49,500 | 0.3% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $3.2M | 37,000 | 0.3% |
| Biogen Inc(BIIB) | COM | 09062X103 | $2.4M | 8,600 | 0.2% |
| Ascendis Pharma A S(ASND) | SPONSORED ADR | 04351P101 | $2.4M | 15,500 | 0.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $1.9M | 44,900 | 0.2% |
| Cellectis S A(CLLS) | SPON ADS | 15117K103 | $1.5M | 83,500 | 0.1% |
| Adobe Systems Incorporated(ADBE) | COM | 00724F101 | $539.0K | 1,100 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $413.6K | 8,716,270 | 0.0% |
| Constellation Brands Inc(STZ) | CL A | 21036P108 | $390.0K | 2,059 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $317.1K | 3,297,451 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $294.3K | 3,279,450 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $261.4K | 960,600 | 0.0% |
| Moderna Inc(MRNA) | COM | 60770K107 | $236.4K | 3,341,950 | 0.0% |
| Blackbaud Inc(BLKB) | COM | 09227Q100 | $229.0K | 4,107 | 0.0% |
| Esperion Therapeutics Inc New(ESPR) | COM | 29664W105 | $203.2K | 5,465,715 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $162.6K | 1,421,128 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $153.8K | 1,128,400 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $143.7K | 5,469,131 | 0.0% |
| Abbott Labs(ABT) | COM | 002824100 | $140.2K | 1,288,285 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $133.1K | 5,282,188 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $108.7K | 153,184 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $101.0K | 324,053 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $101.0K | 243,996 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $99.2K | 1,645,912 | 0.0% |
| Danaher Corporation(DHR) | COM | 235851102 | $97.6K | 453,384 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $96.5K | 1,579,504 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $93.8K | 349,123 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $91.9K | 3,579,919 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $88.6K | 2,217,500 | 0.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $86.4K | 831,450 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $84.3K | 7,431,414 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $79.4K | 949,262 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $75.1K | 3,073,500 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $71.5K | 5,092,000 | 0.0% |
| Stryker Corporation(SYK) | COM | 863667101 | $67.3K | 322,771 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $66.1K | 827,818 | 0.0% |